Cargando…

Neurological and neuropsychiatric disorders associated with COVID-19. Part II: neuropsychiatric disorders and final consideration

Detalles Bibliográficos
Autores principales:	Giacalone, Martina, Tovani-Palone, Marcos Roberto, Marin, Luca, Febbi, Massimiliano, Russano, Tommaso, Giacalone, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Israelita de Ensino e Pesquisa Albert Einstein 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528448/ https://www.ncbi.nlm.nih.gov/pubmed/34730706 http://dx.doi.org/10.31744/einstein_journal/2021CE6464

Ejemplares similares

Neurological and neuropsychiatric disorders associated with COVID-19. Part I: overview and neurological disorders
por: Giacalone, Martina, et al.
Publicado: (2021)

eHealth, telehealth, and telemedicine in the management of the COVID-19 pandemic and beyond: Lessons learned and future perspectives
por: Giacalone, Andrea, et al.
Publicado: (2022)

Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders
por: Ratner, Marcia H., et al.
Publicado: (2019)

Reelin and Neuropsychiatric Disorders
por: Ishii, Kazuhiro, et al.
Publicado: (2016)

Autoantibodies in Neuropsychiatric Disorders
por: Hoffmann, Carolin, et al.
Publicado: (2016)

The genetics of neuropsychiatric disorders
por: Bray, Nicholas J., et al.
Publicado: (2018)

New considerations for hiPSC-based models of neuropsychiatric disorders
por: Hoffman, Gabriel E., et al.
Publicado: (2018)

The Olfactory System as Marker of Neurodegeneration in Aging, Neurological and Neuropsychiatric Disorders
por: Bhatia-Dey, Naina, et al.
Publicado: (2021)

The role of Gadd45b in neurologic and neuropsychiatric disorders: An overview
por: Shen, Xiao-yue, et al.
Publicado: (2022)

Benefits of the Neurogenic Potential of Melatonin for Treating Neurological and Neuropsychiatric Disorders
por: Potes, Yaiza, et al.
Publicado: (2023)

Alternative patterns of deep brain stimulation in neurologic and neuropsychiatric disorders
por: Najera, Ricardo A., et al.
Publicado: (2023)

Reconstruction surgery in head and neck cancer patients amidst the COVID-19 pandemic: Current practice and lessons for the future
por: Lizambri, Daniele, et al.
Publicado: (2023)

Kynurenine Pathway of Tryptophan Metabolism in Neuropsychiatric Disorders: Pathophysiologic and Therapeutic Considerations
por: Muneer, Ather
Publicado: (2020)

The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets
por: Vitale, Rosa Maria, et al.
Publicado: (2021)

nNOS and Neurological, Neuropsychiatric Disorders: A 20-Year Story
por: Zhu, Li-Juan, et al.
Publicado: (2023)

Fatty acids and neuropsychiatric disorders
por: Puri, Basant K
Publicado: (2008)

Maintenance Pharmacotherapies for Neuropsychiatric Disorders
por: Richards, Stephanie
Publicado: (2013)

Neuropsychiatric disorders in Cushing's syndrome
por: Pivonello, Rosario, et al.
Publicado: (2015)

Epigenetic Regulations in Neuropsychiatric Disorders
por: Kuehner, Janise N., et al.
Publicado: (2019)

Neuropsychiatric disorders and COVID-19
por: Charlton, Elizabeth, et al.
Publicado: (2021)

Neuropsychiatric disorders and COVID-19
por: Finsterer, Josef
Publicado: (2021)

Neuropsychiatric disorders and COVID-19
por: Burchill, Ella, et al.
Publicado: (2021)

The Histaminergic System in Neuropsychiatric Disorders
por: Cheng, Li, et al.
Publicado: (2021)

Gut Bacteria and Neuropsychiatric Disorders
por: Dicks, Leon M. T., et al.
Publicado: (2021)

Gut microbiome in neuropsychiatric disorders
por: MEJÍA-GRANADOS, Diana Marcela, et al.
Publicado: (2022)

Gut Microbiota and Neuropsychiatric Disorders
por: Bidaki, Reza, et al.
Publicado: (2023)

Editorial: The heterogeneity of neuropsychiatric disorders
por: Wu, Zhao-Min, et al.
Publicado: (2023)

Transcranial Direct Current Stimulation in Treatment of Child Neuropsychiatric Disorders: Ethical Considerations
por: Auvichayapat, Narong, et al.
Publicado: (2022)

The Significance of the Default Mode Network (DMN) in Neurological and Neuropsychiatric Disorders: A Review
por: Mohan, Akansha, et al.
Publicado: (2016)

A Genomic and Epigenomic Approach for Studying Neuropsychiatric Disorders Associated to Early-life Stress: Part II
por: Pappalardo, Xena Giada, et al.
Publicado: (2018)

Ethopharmacology: Primate Models of Neuropsychiatric Disorders
por: Krystal, John H.
Publicado: (1984)

Crosstalk between metabolic and neuropsychiatric disorders
por: Kaidanovich-Beilin, Oksana, et al.
Publicado: (2012)

Novel Therapeutic Drugs for Neuropsychiatric Disorders
por: Hashimoto, Kenji
Publicado: (2010)

NMDA Receptor Activity in Neuropsychiatric Disorders
por: Lakhan, Shaheen E., et al.
Publicado: (2013)

Redox Modulations, Antioxidants, and Neuropsychiatric Disorders
por: Fraunberger, Erik A., et al.
Publicado: (2016)

The role of sex and gender in neuropsychiatric disorders
por: Thibaut, Florence
Publicado: (2016)

Pluripotent stem cells in neuropsychiatric disorders
por: Soliman, M A, et al.
Publicado: (2017)

Modulating Neuroinflammation to Treat Neuropsychiatric Disorders
por: Radtke, Franziska A., et al.
Publicado: (2017)

Neuropsychiatric Disorders in Chronic Kidney Disease
por: Simões e Silva, Ana Cristina, et al.
Publicado: (2019)

MMPs in learning and memory and neuropsychiatric disorders
por: Beroun, Anna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jksienflu6erhol8vb82qifa9f